Global Acute Migraine Drugs Market Report 2023: A $14.06 Billion Market by 2028 Featuring Key Players - Eli Lilly and Co, GSK, Bayer, J&J, Teva, AbbVie, Novartis, Merck, Pfizer, & Boehringer Ingelheim
March 10, 2023 05:53 ET
|
Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By...
Global Migraine Drugs Market 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts
January 11, 2023 05:28 ET
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Worldwide Migraine Drugs Industry to 2026 - Featuring Allergan, Amgen and Eisai Among Others
October 22, 2021 08:33 ET
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Global Migraine Drugs Market to 2025: Growing Demand for Electrical Nerve Stimulating Devices to Treat Migraine
December 15, 2020 05:08 ET
|
Research and Markets
Dublin, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The "Migraine Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...